Skip to content
10-Q

Quarterly Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-13-028768

← back to feed
Filed
May 14, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · May 14, 2013 21.63M sh
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$287.05K
Operating Cash Flow Q1 2013 · Mar 31, 2012 −$460.43K
Stockholders Equity Q1 2013 · Mar 31, 2013 −$2.12M
Stockholders Equity Q1 2013 · Dec 31, 2012 −$1.68M
Current Liabilities Q1 2013 · Mar 31, 2013 $2.44M
Current Liabilities Q1 2013 · Dec 31, 2012 $2.25M
Current Assets Q1 2013 · Mar 31, 2013 $312.84K
Current Assets Q1 2013 · Dec 31, 2012 $571.8K
Total Assets Q1 2013 · Mar 31, 2013 $315.17K
Total Assets Q1 2013 · Dec 31, 2012 $575.27K
Cash And Equivalents Q1 2013 · Mar 31, 2012 $1.66M
Cash And Equivalents Q1 2013 · Dec 31, 2011 $2.13M
Sga Expense Q1 2013 · Mar 31, 2012 $188.78K
Rd Expense Q1 2013 · Mar 31, 2012 $298.83K
Net Income Q1 2013 · Mar 31, 2012 −$659.43K
Revenue Q1 2013 · Mar 31, 2012 $0